News

U.S. Supreme Court rebuffs J&J appeal over $2 billion baby powder judgement WASHINGTON  - The U.S. Supreme Court on Tuesday declined to hear Johnson & Johnson's bid to overturn a $2.12 billion damages award to women who blamed their ovarian cancer on asbestos in the company's baby powder and other talc products. The justices turned away a J&J appeal and left in place a Missouri state court ruling in litigation brought by 22 women whose claims were heard together in one trial. The Missouri Court of Appeals, an intermediate state appellate co...
U.S. Supreme Court rebuffs J&J appeal over $2 billion baby powder judgement
U.S. Supreme Court rebuffs J&J appeal over $2 billion baby powder judgement
Source: Reuters
2/06/2021 12:56:34 PM
J&J COVID-19 vaccine under EU review over blood clots Europe's drug regulator said on Friday that it is reviewing rare blood clots in four people in the United States who received Johnson & Johnson's COVID-19 vaccine. The European Medicines Agency's safety committee has also been looking at how AstraZeneca's COVID-19 vaccine is associated with very rare cases of unusual blood clots and said it was now reviewing reports of capillary leak syndrome in people given AstraZeneca's vaccine. Johnson & Johnson (J&J) ...
J&J COVID-19 vaccine under EU review over blood clots
J&J COVID-19 vaccine under EU review over blood clots
Source: Reuters
10/04/2021 9:58:10 AM
ISS joins Glass Lewis in recommending vote against J&J CEO`s pay package Proxy advisory firm Institutional Shareholder Services (ISS) has joined Glass Lewis in recommending investors reject a proposed pay package of nearly $30 million for Johnson & Johnson Chief Executive Officer Alex Gorsky. J&J is attracting investor scrutiny because it partially shields Gorsky from some $9 billion in costs over two years that have arisen from lawsuits claiming the healthcare company fueled the U.S. opioid crisis and allegations of asbestos in its talc baby powder. ...
ISS joins Glass Lewis in recommending vote against J&J CEO`s pay package
ISS joins Glass Lewis in recommending vote against J&J CEO`s pay package
Source: Reuters
9/04/2021 11:50:41 AM
Exclusive: J&J `under stress` to meet EU second-quarter vaccine supply goal - source BRUSSELS  - Johnson & Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its COVID-19 vaccine to the bloc in the second quarter of the year, an EU official told Reuters. Any delay would be a further blow to EU's vaccination plans, which have been hampered by bumpy supplies from other vaccine makers and a slow rollout of shots in many member states. J&J told the EU last week that issues with the supply ...
Exclusive: J&J `under stress` to meet EU second-quarter vaccine supply goal - source
Exclusive: J&J `under stress` to meet EU second-quarter vaccine supply goal - source
Source: Reuters
10/03/2021 9:30:43 AM
J&J waiting on new plant approval to ship high volumes of vaccine: executive Johnson & Johnson is waiting on regulatory approval of a new, larger plant operated by contract manufacturer Catalent Inc to begin large-scale U.S. deliveries of its just-authorized COVID-19 vaccine following initial shipments this week, a top J&J executive said on Monday. J&J will ship nearly 4 million doses of the one-shot vaccine around the United States this week and expects to deliver another 16 million doses later this month. But none is expected to go out next week. &...
J&J waiting on new plant approval to ship high volumes of vaccine: executive
J&J waiting on new plant approval to ship high volumes of vaccine: executive
Source: Reuters
2/03/2021 10:54:52 AM
India says J&J interested in making COVID-19 vaccine in country NEW DELHI  - Johnson & Johnson is interested in manufacturing its COVID-19 vaccine in India, a government official told a news conference on Tuesday. India also currently has no concern over the efficacy of the AstraZeneca vaccine that is being used in the country's massive inoculation campaign, Vinod Kumar Paul said.   (Reporting by Krishna N. Das and Sai Sachin Ravikumar; Editing by Gareth Jones)
India says J&J interested in making COVID-19 vaccine in country
India says J&J interested in making COVID-19 vaccine in country
Source: Reuters
9/02/2021 5:24:34 PM
Wall Street falls after J&J vaccine data; GameStop effect weighs By Devik Jain and Shreyashi Sanyal  U.S. stock indexes fell on Friday after COVID-19 vaccine data from Johnson & Johnson hurt sentiment, while a standoff between Wall Street hedge funds and small, retail investors weighed. Johnson & Johnson fell 3.9% after the drugmaker said its single-dose vaccine was 72% effective in preventing COVID-19 in the United States, with a lower rate of 66% observed globally. The results compare to the high bar set by two authorized vaccines f...
Wall Street falls after J&J vaccine data; GameStop effect weighs
Wall Street falls after J&J vaccine data; GameStop effect weighs
Source: Reuters
30/01/2021 9:52:51 AM